SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: KLH who wrote (2331)11/23/1998 11:00:00 AM
From: Exacctnt  Read Replies (1) | Respond to of 2553
 
KLH, "Both GENZL and GZTC seem to be exhibiting the same weakness in price." Isn't it ironic that GENZ is trading at its high. Perhaps it's an indication that the way to play the subs is to invest in the parent. You might not get as much in gains if the subs take off, however there is less risk. Isn't hindsight great?

Regards,
Bob


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News